Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window?
Phase of Trial: Phase IV
Latest Information Update: 27 Mar 2014
At a glance
- Drugs Raloxifene (Primary) ; Teriparatide (Primary)
- Indications Postmenopausal osteoporosis
- Focus Biomarker; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 16 Mar 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 02 Aug 2010 New trial record